DXM Abuse Prevention Act of 2015

Bill: 114-hr-3250
Sponsor: Rep. Johnson, Bill [R-OH-6]
Introduced: 2015-07-28 in the House
Policy area: Health
Subjects: Child health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Licensing and registrations
Prescription drugs
Retail and wholesale trades

Summary:
action_date: 2015-07-28
text: 

DXM Abuse Prevention Act of 2015

 
This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Civil monetary penalties that escalate upon repeated violation are imposed.
 
 
To possess or receive unfinished DXM, a person must be registered with the Department of Health and Human Services as a producer of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Unfinished DXM may be distributed only to these authorized persons. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations. 

action_date: 2016-07-08
text: 
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
 

DXM Abuse Prevention Act of 2015

 
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.
 
(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations. 


Legislative actions:
action_date: 2016-07-08
text: Placed on the Union Calendar, Calendar No. 520.
action_date: 2016-07-08
text: Reported by the Committee on Energy and Commerce. H. Rept. 114-672.
action_date: 2016-07-08
text: Reported by the Committee on Energy and Commerce. H. Rept. 114-672.
action_date: 2016-04-27
text: Ordered to be Reported by Voice Vote.
action_date: 2016-04-27
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-26
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-25
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-20
text: Forwarded by Subcommittee to Full Committee by Voice Vote .
action_date: 2016-04-20
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2015-07-31
text: Referred to the Subcommittee on Health.
action_date: 2015-07-28
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-07-28
text: Introduced in House
action_date: 2015-07-28
text: Introduced in House